Finnrick - Ensuring a Safer and More Transparent Supply Chain
Steady Meds

Steady Meds

Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Steady Meds between 26 Jan 2026 and 13 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
Steady Meds
Retatrutide
Tested 7 Samples
Last test 13 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Steady Meds

Samples are tested in commercial labs

Tests Count

7

Scores

AVG6.6MIN0.0MAX9.3

Last

13 Mar 2026

First

26 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
13 Mar 2026View0.030mg
⚠️ Sample does not contain Retatrutide
(no batch ID)No Label / Silver Crimp / Green CapLab GPublic
12 Mar 2026View6.110mg8.85mg-11.5%99.90%(no batch ID)Silver Label / Silver Crimp / Green CapLab EPublic
3 Mar 2026View8.010mg10.4mg+4.0%99.90%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
20 Feb 2026View7.610mg9.39mg-6.1%99.90%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
10 Feb 2026View7.210mg10.6mg+6.0%99.70%(no batch ID)(no data)Lab GPublic
9 Feb 2026View8.030mg29.9mg-0.3%99.90%(no batch ID)No Label / Silver Crimp / Clear Yellow CapLab EPublic
26 Jan 2026View9.320mg20.4mg+2.0%99.60%Nov 2025White Label / Copper Crimp / Clear CapLab EPublic